|06/22/17||4||Statement of changes in beneficial ownership of securities||2|
|06/07/17||4||Statement of changes in beneficial ownership of securities||2|
|06/06/17||EFFECT||Notice of Effectiveness||1|
|06/06/17||424B3||Prospectus filed pursuant to Rule 424(b)(3)||455|
|06/02/17||8-K||Current report filing
|06/02/17||425||Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
|06/02/17||S-4/A||Registration of securities issued in business combination transactions||470|
|06/01/17||4||Statement of changes in beneficial ownership of securities||2|
|05/19/17||4||Statement of changes in beneficial ownership of securities||3|
|05/19/17||S-4||Registration of securities issued in business combination transactions||471|
Nivalis Therapeutics is not responsible for the content on linked websites.
The document you requested is located on the Journal of Applied Physiology website. A subscription is required to view the document.